SITC 2017

November 8-12 | Gaylord National Resort & Convention Center, National Harbor, MD

Visualize a new path forward

Empowering the immune system to recognize and eliminate tumors has tremendous potential to change the way cancer is treated and eventually cured. At Fluidigm, we enable comprehensive cellular profiling of the immune system and the tumor microenvironment with proven mass cytometry and microfluidics technologies.

Whether you seek to target new biomarkers and pathways or to optimize the effectiveness of checkpoint inhibitors, CAR T cells or cancer vaccines, Fluidigm can help you identify new insights to reach your next research breakthrough.

Join us for a Dinner Seminar

Comprehensive Characterization of the Tumor Microenvironment with Imaging Mass Cytometry

Please join us for an evening of cocktails, dinner and presentations by leading researchers who are using Imaging Mass Cytometry™ to gain a comprehensive view of complex cellular phenotypes and their relationships in the context of the tumor microenvironment.

When: Thursday, November 9, 2017

6:00‒7:00 pm Cocktails
7:00–10:00 pm Dinner and presentations

Where: The Sunset Room
137 National Plaza #200
National Harbor, Maryland


Bernd Bodenmiller Analysis of tissue ecosystems in health and disease by Imaging Mass Cytometry
Bernd Bodenmiller, PhD—University of Zurich
Kurt Schalper Understanding the immune composition of human lung cancer using Imaging Mass Cytometry 
Kurt Schalper, MD, PhD—Yale University

See Product Presentations

Visit Fluidigm at Booth 325 and hear about the Hyperion™ Imaging System, an exciting new product that is transforming tumor imaging.

Exhibition Dates & Hours
Friday, November 10: 12:30–7:45 pm
Saturday, November 11: 12:30–8:00 pm 

Hyperion Imaging System

Comprehensively interrogate complex cellular phenotypes and their interrelationships in the context of the tumor microenvironment with Imaging Mass Cytometry.

Hyperion Imaging System

Helios™, a CyTOF® system

Deeply profile immune and tumor cell populations for phenotype and function, all in a single tube.


Biomark HD

Reveal the molecular signatures of tumor immune response using the Advanta™ Immuno-Oncology Gene Expression Assay on the Biomark™ HD.

 Biomark HD

Visit Posters and Presentations Featuring Fluidigm Technology

Presentations: Thursday, November 9



Presenter, Institution


10:35‒11:00 am Myeloid cells in lung tumors using CyTOF® Miriam Merad, MD, PhD
Icahn School of Medicine at Mount Sinai
Workshop on Single Cell Techniques/ Session II, Tumor Immune Microenvironment
11:00‒11:25 am Computational methods for analyzing single cells in the tumor microenvironment Dana Pe’er, PhD
Sloan Kettering Cancer Center

Posters: Friday, November 10 and Saturday, November 11



Presenter, Institution


P80 Testing systems immune monitoring by mass cytometry for clinical research Caroline Roe, BS
Vanderbilt University
Biomarkers and Immune Monitoring
P173 Mass cytometry based immunophenotyping of tumor-reactive T cells in human cancer reveals subpopulations with coordinate inhibitory molecule expression Monika Aleksandra Eiva, BS
University of Pennsylvania
Cellular Therapy Approaches
P379 Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade Spencer Wei, PhD
The University of Texas MD Anderson Cancer Center
Mechanisms of Efficacy or Toxicity
P489 Studying the cellular heterogeneity and spatial arrangement of immune cells in FFPE sections of Hodgkin Lymphoma and normal lymph node using a highly multiplexed Imaging Mass Cytometry Mohan Singh, PhD
University of Southern California
Tumor Microenvironment (Mechanisms and Therapies)

Social Media

Can't make it to all of the sessions? Follow @fluidigm with #SITC2017 and like us on Facebook for scientific and event updates.

For Research Use Only. Not for use in diagnostic procedures.